10.5 C
New York
Sunday, April 2, 2023

There’s No Need To Panic Or Freeze When It Comes To Masimo Corporation (NASDAQ: MASI)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Masimo Corporation (MASI) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$2.97, or -1.69%, to $172.96. The Masimo Corporation has recorded 7,572 volume in the after hours trading session.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NASDAQ and operates within the Medical Instruments & Supplies industry segment. At the end of the last regular session, the stock closed at $175.93 and fluctuated between $184.96 as its day high and $172.65 as its day low. The current market capitalization of Masimo Corporation is $9.27B. A total of 0.64 million shares were traded on the day, compared to an average of 406.51K shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, MASI has seen 4 BUY and 0 SELL insider trades, representing the acquisition of 7,040 and the disposition of 0 shares. Over the last 12 months, there were 15 BUYs and 0 SELLs from insiders. Insiders purchased 50,506 shares during that period but sold 0.

In the most recent transaction, KIANI JOE E bought 7,040 shares of MASI for 144.79 per share on Dec 15. After the transaction, the CEO and Chairman of the Board now owns 46,818 company shares. In a previous transaction on Nov 14, KIANI JOE E bought 31,994 shares at 123.99 per share. MASI shares that CEO and Chairman of the Board owns now total 39,778.

Among the insiders who bought shares, KIANI JOE E acquired of 7,784 shares on Nov 11 at a per-share price of $129.27. This resulted in the CEO and Chairman of the Board holding 7,784 shares of MASI after the transaction.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for MASI in the last 3 months, the mean price target is $170.63 with high estimates of $195.00 and low estimates of $135.00. In terms of 52-week highs and lows, MASI has a high of $176.42 and a low of $108.89.

As of this writing, MASI has an earnings estimate of $1.17 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $1.21 per share and a lower estimate of $1.15. The company reported an EPS of $1.35 in the last quarter, which was 12.50% higher than expectations of $1.2.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MASI is Overweight with a score of 4.43. A total of 6 analysts rated the stock as Buy while 1 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles